EDLIN RICHARD A. sold 23.1% of their position (6.80K shares) of EAGLE PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $210.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/8/2022ACC: 0001209191-22-049205
Director
Since Jan 2019
-6.80K
Net shares
Net seller
$210.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.80K
Price / share
$30.99
Trade value
$210.73K
% of position
23.1%
9/6/2022
29.40K→22.60K
Total
Net shares
−6.80K
Net value
-$210.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/6/2022 | S · Sale | −6.80K | $30.99 | $210.73K | 23.1% | 29.40K | 22.60K |
| Total | −6.80K | -$210.73K | ||||||
Derivative Transactions0
No derivative transactions reported